Policy & Regulation

Planning for the Unified Patent Court

Read more

An analysis of accelerated approval for cancer drugs

Read more

Avastin vs Lucentis: the drug reimbursement dilemma of the century

Read more

EU pharmacovigilance law comes into force

Read more

Commentary on the impact of pharmacovigilance legislation

Read more

Focus on ophthalmology: new treatment modality

Read more

Reforming the EU Clinical Trials Directive

Read more

The outlook for new clinical trials legislation in Europe

Read more

UK Biotech needs a subtle culture shift

Read more

FDA lays out regulatory science strategy

Read more